Effect of Xijiao Dihuang Combined Prescription on Human Dendritic Cell Function Induced by Lipopolysaccharide.
10.19746/j.cnki.issn.1009-2137.2022.04.031
- Author:
Wu-Xia YANG
1
;
Yu-Hong WU
2
;
Meng-Xiao WANG
3
;
Run-Feng NI
3
;
Li-Wei FAN
3
;
Run-Jie LI
2
;
Meng LI
2
;
Ai-Di WANG
4
;
Bao-Shan LIU
5
Author Information
1. Tianjin Medical University Tianjin 300041, China.
2. General Hospital of Tianjin Medical University, Tianjin 300041, China.
3. Tianjin Medical University, Tianjin 300041, China.
4. General Hospital of Tianjin Medical University, Tianjin 300041, China,E-mail：wangaidi@tmu.edu.cn.
5. General Hospital of Tianjin Medical University, Tianjin 300041, China,E-mail：j33387@qq.com.
- Publication Type:Journal Article
- Keywords:
Xijiao Dihuang combined prescription;
dendritic cells;
inflammatory factor;
lipopolysaccharide;
primary immune thrombocytopenia
- MeSH:
Animals;
B7-1 Antigen/pharmacology*;
Cell Differentiation;
Dendritic Cells;
HLA-DR Antigens/pharmacology*;
Humans;
Interleukin-12/pharmacology*;
Interleukin-6;
Lipopolysaccharides/pharmacology*;
Medicine, Chinese Traditional;
NF-kappa B;
Prescriptions;
Purpura, Thrombocytopenic, Idiopathic;
Rats;
Toll-Like Receptor 4;
Tumor Necrosis Factor-alpha/pharmacology*
- From:
Journal of Experimental Hematology
2022;30(4):1176-1181
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effects of drug-containing serum of Xijiao Dihuang combined prescription(XJDH) on the related functions of dendritic cells(DCs) induced in vitro, and to explore the mechanisms underlying the effectiveness of XJDH treatment on primary immune thrombocytopenia(ITP).
METHODS:Peripheral blood samples were colle-ted from 6 healthy volunteers. Mononuclear cells were isolated by density gradient centrifugation, and CD14+ mononuclear cells were collected by the magnetic separation technique. CD14+ mononuclear cells were induced into immature DCs by recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) and recombinant human interleukin 4 (IL-4). Immature DCs were divided into three groups: control group, model group and XJDH group. CCK-8 assay was used to determine the intervention concentration and time of drug-containing serum. Lipopolysaccharide(LPS) with the final concentration of 1 μg/ml was added to model group and XJDH group respectively for 24 h to induce DCs maturation. Normal rat serum was added to control group and model group, and XJDH was added to XJDH group for 24 h. Flow cytometry was used to detect the levels of CD80, CD83 and HLA-DR on the surface of DCs. Western blot was used to detect the expression of TLR4 and NF-κB, and levels of IL-6, IL-12 and TNF-α in cell supernatant was detected by ELISA.
RESULTS:Compared with the control group, LPS stimulation increased the expression of CD80, CD83 and HLA-DR, with subsequent increasing expression of TLR4 and NF-κB, as well as IL-6, IL-12 and TNF-α increased(P<0.05). In comparison with model group, the expression of DCs surface molecules CD80, CD83 and HLA-DR, DCs' expression of TLR4 and NF-κB protein, and the levels of IL-6, IL-12 and TNF-α in the cell supernatant of XJDH group decreased after the intervention of XJDH (P<0.05).
CONCLUSION:Drug containing serum of Xijiao Dihuang combined prescription can down-regulate TLR4/NF-κB signaling pathway related protein expression, inhibit DCs maturation, and reduce proinflammatory factor secretion, which may be one of the mechanisms of drug-containing serum of Xijiao Dihuang combined prescription in the treatment of immune thrombocytopenia.
